Oncogenesis, Published online: 21 May 2026; doi:10.1038/s41389-026-00628-y

Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways

Oncogenesis, Published online: 20 May 2026; doi:10.1038/s41389-026-00625-1

Metabolic vulnerabilities in pleural mesothelioma

Oncogenesis, Published online: 16 May 2026; doi:10.1038/s41389-026-00623-3

Multi-omics analysis reveals LARP1 as a key integrator of translation and metabolism in AML

Oncogenesis, Published online: 15 May 2026; doi:10.1038/s41389-026-00627-z

SHP1 expression in tumor-associated dendritic cells drives immunoevasion via impairing CD8⁺ memory T cell responses

Oncogenesis, Published online: 15 May 2026; doi:10.1038/s41389-026-00629-x

Metabolic vulnerabilities and therapeutic opportunities in diffuse large B-cell lymphoma

Oncogenesis, Published online: 12 May 2026; doi:10.1038/s41389-026-00620-6

Imbalances of mitochondrial dynamics in solid tumors

Oncogenesis, Published online: 08 May 2026; doi:10.1038/s41389-026-00621-5

Ubiquitin-specific protease 11 suppresses cuproptosis in colorectal cancer by regulating the ubiquitination and stability of ISCU

Oncogenesis, Published online: 07 May 2026; doi:10.1038/s41389-026-00622-4

Metabolic modulation of immune cell function: mechanisms and therapeutic implications in cancer immunotherapy

Oncogenesis, Published online: 19 April 2026; doi:10.1038/s41389-026-00619-z

PRMT6-mediated EZH2 arginine methylation is critical for breast cancer development

Oncogenesis, Published online: 17 April 2026; doi:10.1038/s41389-026-00615-3

Metastasis suppressing properties of the cell-surface anchored serine protease prostasin: new functional and mechanistic insights from breast cancer

Oncogenesis, Published online: 13 April 2026; doi:10.1038/s41389-026-00614-4

SREBP2 regulates CCDC25 expression and promotes tumor metastasis in Triple-Negative Breast Cancer

Oncogenesis, Published online: 10 April 2026; doi:10.1038/s41389-026-00616-2

Correction: Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma

Oncogenesis, Published online: 06 April 2026; doi:10.1038/s41389-026-00612-6

Choroid plexus carcinoma: state of the field and emerging directions

Oncogenesis, Published online: 02 April 2026; doi:10.1038/s41389-026-00603-7

GPX3 suppresses gallbladder cancer progression by modulating redox balance, glycolysis, and anti-tumor immunity

Oncogenesis, Published online: 01 April 2026; doi:10.1038/s41389-026-00611-7

Alternatively activated macrophages cause DNA damage through an arginase 1-mediated bystander effect and promote epithelial cell transformation

Oncogenesis, Published online: 26 March 2026; doi:10.1038/s41389-026-00608-2

The oncogenic control of nucleotide synthesis

Oncogenesis, Published online: 18 March 2026; doi:10.1038/s41389-026-00610-8

Correction: LXRα limits TGFβ-dependent hepatocellular carcinoma associated fibroblast differentiation

Oncogenesis, Published online: 18 March 2026; doi:10.1038/s41389-026-00607-3

Teriflunomide modulates the PD-1/PD-L1 axis and enhances antitumor immunity in colorectal cancer

Oncogenesis, Published online: 17 March 2026; doi:10.1038/s41389-026-00609-1

IFFO1 inhibits breast cancer by coordinating mitochondrial fission and fatty acid synthesis via the LaminA/C-PGC1α axis

Oncogenesis, Published online: 11 March 2026; doi:10.1038/s41389-026-00605-5

Inhibition of ZBTB7B-mediated ADPGK transcription by NEDD4 impedes glycolysis and progression of lung adenocarcinoma